Smith & Nephew plc, founded in 1856 and headquartered in London, is a global medical technology company dedicated to wound management, surgical devices, and orthopedics. The company is known for its innovative products such as advanced wound care solutions, robotic-assisted surgery systems, and orthopedic implants.
| Bond Name | Country | Maturity | Coupon(%) | |||
|---|---|---|---|---|---|---|
| No data found! | ||||||
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
In 2020, Smith & Nephew issued €500 million of senior unsecured bonds, marking their first foray into the Eurobond market aimed at refinancing existing debt and enhancing liquidity. The 10-year bond had a yield of 1.625%, appealing to investors amid a backdrop of low-interest rates. Historically, the company has maintained an active presence in capital markets, including notable bond issuances in 2017 for $1 billion to finance acquisitions. Current yields remain competitive within the medical technology sector, reflecting strong investor confidence in Smith & Nephew’s financial stability and growth prospects.